Medical Technology - Netherlands

Netherlands

The Medical Technology market market in the Netherlands is estimated to achieve a revenue of US$5.57bn in 2024.
Among the various markets within the market, Medical Devices is expected to be the largest, with a projected market volume of US$5.10bn in the same year.
The revenue is anticipated to demonstrate a compound annual growth rate (CAGR 2024-2029) of 4.80%, resulting in a market volume of US$7.04bn by 2029.
When compared globally, the United States is forecasted to generate the highest revenue, reaching US$211.10bn in 2024.
The Netherlands is at the forefront of medical technology innovation, with a strong focus on precision medicine and digital health solutions.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Netherlands is experiencing significant growth and development due to several key factors.

Customer preferences: Customers in the Netherlands have a strong preference for high-quality and innovative medical technology products. They value products that are reliable, efficient, and easy to use. Additionally, there is a growing demand for personalized medical technology solutions that cater to individual needs and preferences. Customers also prioritize products that are environmentally friendly and sustainable, as the Netherlands has a strong focus on sustainability and green initiatives.

Trends in the market: One of the major trends in the Medical Technology market in Netherlands is the increasing adoption of digital health solutions. The use of telemedicine, remote patient monitoring, and digital health platforms is on the rise, driven by the need for improved access to healthcare services and the convenience they offer. This trend is further fueled by the advancements in technology, such as artificial intelligence and Internet of Things, which enable the development of innovative and connected medical devices. Another trend in the market is the growing focus on preventive healthcare. There is a shift towards proactive healthcare management, with an emphasis on early detection and prevention of diseases. This has led to the development of medical technology products that enable individuals to monitor their health and take preventive measures. Wearable devices, home diagnostics kits, and mobile health apps are becoming increasingly popular among consumers.

Local special circumstances: The Netherlands has a well-developed healthcare system and is known for its high standards of care. The country has a strong focus on research and innovation, with several leading academic and research institutions. This creates a favorable environment for the development and adoption of medical technology solutions. The Netherlands also has a supportive regulatory framework that encourages innovation and ensures patient safety.

Underlying macroeconomic factors: The Netherlands has a stable and prosperous economy, which provides a favorable market for medical technology companies. The country has a high per capita income and a well-established healthcare infrastructure, creating a strong demand for medical technology products. Additionally, the aging population in the Netherlands is driving the need for advanced medical technology solutions to address age-related health issues. The government is also investing in healthcare and research, further supporting the growth of the Medical Technology market in Netherlands.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.